Insider Transactions in Q4 2023 at Spruce Biosciences, Inc. (SPRB)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2023
|
Ralph William Charlton Iii CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
9,361
+14.46%
|
$0
$0.98 P/Share
|
|
Dec 29
2023
|
Samir M. Gharib PRESIDENT AND CFO |
BUY
Grant, award, or other acquisition
|
Direct |
11,255
+5.26%
|
$0
$0.98 P/Share
|
|
Dec 15
2023
|
Javier B. Szwarcberg CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
38,384
-26.34%
|
$38,384
$1.66 P/Share
|
|
Dec 15
2023
|
Javier B. Szwarcberg CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
111,000
+43.24%
|
-
|
|
Dec 15
2023
|
Samir M. Gharib PRESIDENT AND CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
36,095
-9.25%
|
$36,095
$1.66 P/Share
|
|
Dec 15
2023
|
Samir M. Gharib PRESIDENT AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
112,250
+21.84%
|
-
|
|
Dec 15
2023
|
Ralph William Charlton Iii CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
10,980
-19.27%
|
$10,980
$1.66 P/Share
|
|
Dec 15
2023
|
Ralph William Charlton Iii CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
31,750
+35.78%
|
-
|